Los Angeles Biotechnology Network
  • Home
  • About
  • News
    • All LABN News
    • Trending LABN News
  • Jobs
    • All LABN Jobs
    • Post A Job
  • Subscribe
  • Contact
News Ticker
  • [ June 10, 2023 ] Graduating senior lights the path for transfer students – through her award-winning research and mentoring Los Angeles Biotech News
  • [ June 10, 2023 ] Postdoctoral Scientist – Karsh Division of Gastroenterology and Hepatology – Part-Time – CEDARS-SINAI – Los Angeles, CA Los Angeles Biotech Jobs
  • [ June 10, 2023 ] Adcomm votes yes on Leqembi full OK; Merck brings first IRA lawsuit; Special: LGBTQ+ leaders; Best-paying biopharma jobs; and more Los Angeles Biotech News
  • [ June 10, 2023 ] Scientist, Cell Biology – Thermo Fisher Scientific – West Hills, CA Los Angeles Biotech Jobs
  • [ June 10, 2023 ] Security Officer – Biotechnology Company – Allied Universal® – Oceanside, CA Los Angeles Biotech Jobs
HomeLos Angeles Biotech NewsPuma Biotechnology Announces Publication of Neratinib Abstract Titles for the 2022 ASCO Annual Meeting

Puma Biotechnology Announces Publication of Neratinib Abstract Titles for the 2022 ASCO Annual Meeting

April 27, 2022 Los Angeles Biotechnology Network News Los Angeles Biotech News Comments Off on Puma Biotechnology Announces Publication of Neratinib Abstract Titles for the 2022 ASCO Annual Meeting
LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology announced the titles of two abstracts for neratinib poster presentations at the ASCO 2022 Annual Meeting in June.

Click to view original post

Previous

Amgen touts its latest cut of longterm Repatha data, still hunting elusive billions for PCSK9 franchise

Next

Amgen vows to fight $7.1B tax bill tied to Puerto Rico manufacturing unit

Follow/Subscribe

POST A JOB
Tweets by LABioNetwork

Copyright © 2021 Biotech Networks, LLC

Want to Save Time?

Get Trending News & Jobs Delivered